SCHEMBL6905443

SCHEMBL6905443

O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COB(O)O

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MPI P34949 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9814302 0.76 MPI (0.37) MPI
SCHEMBL459484 0.75 MPI (0.39) MPI
SCHEMBL458492 0.75 MPI (0.39) MPI
SCHEMBL458601 0.75 MPI (0.39) MPI
SCHEMBL4160815 0.75 MPI (0.39) MPI
SCHEMBL10489052 0.75 MPI (0.39) MPI
SCHEMBL565806 0.75 MPI (0.39) MPI
SCHEMBL1586372 0.75 MPI (0.39) MPI
SCHEMBL2889691 0.75 MPI (0.39) MPI
SCHEMBL2337805 0.75 MPI (0.39) MPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115785137-A Synthesis and application of peptide borate compound 江苏正大丰海制药有限公司 2023-03-14 CN claimed
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2021-07-15 US claimed
EP-3805237-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) 2021-04-14 EP claimed
CN-112384519-A Synthesis and application of peptide borate compound 江苏正大丰海制药有限公司 2021-02-19 CN claimed
CN-110540547-A Synthesis and application of peptide borate compound QIN YANRU 2019-12-06 CN claimed
WO-2019228299-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND 江苏正大丰海制药有限公司 (CN) 2019-12-05 WO claimed
EP-3805237-B1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND JIANGSU CHUANGTE PHARMACEUTICAL TECH CO LTD (CN) 2026-01-28 EP disclosed
CN-115785137-A Synthesis and application of peptide borate compound 江苏正大丰海制药有限公司 2023-03-14 CN disclosed
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2023-01-03 US disclosed
CN-112384519-B Synthesis and application of peptide borate compound 江苏正大丰海制药有限公司 2022-11-25 CN disclosed
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO., LTD. (CN) 2021-07-15 US disclosed
EP-3805237-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) 2021-04-14 EP disclosed
CN-112384519-A Synthesis and application of peptide borate compound 江苏正大丰海制药有限公司 2021-02-19 CN disclosed
CN-110540547-A Synthesis and application of peptide borate compound QIN YANRU 2019-12-06 CN disclosed
WO-2019228299-A1 SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND 江苏正大丰海制药有限公司 (CN) 2019-12-05 WO disclosed
US-20040197366-A1 Stabilized insect bait formulation and method WHITMIRE MICRO-GEN RESEARCH LABORATORIES, INC. 2004-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214377-A1 SYNTHESIS OF PEPTIDE BORATE ESTER COMPOUND AND USE THEREOF SEM1, VIP, PSMB11 MPI 2087/4885
US-11542283-B2 Synthesis of peptide borate ester compound and use thereof SEM1, VIP, PSMB11 MPI 2087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.